Kazunari Aoki

521 total citations
24 papers, 302 citations indexed

About

Kazunari Aoki is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Kazunari Aoki has authored 24 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 8 papers in Oncology and 8 papers in Immunology. Recurrent topics in Kazunari Aoki's work include Hematopoietic Stem Cell Transplantation (10 papers), Acute Myeloid Leukemia Research (8 papers) and Lymphoma Diagnosis and Treatment (5 papers). Kazunari Aoki is often cited by papers focused on Hematopoietic Stem Cell Transplantation (10 papers), Acute Myeloid Leukemia Research (8 papers) and Lymphoma Diagnosis and Treatment (5 papers). Kazunari Aoki collaborates with scholars based in Japan, United States and Sweden. Kazunari Aoki's co-authors include Takayuki Ishikawa, Akiko Matsushita, Sumie Tabata, Tadakazu Kondo, Takayuki Takahashi, Yoshiko Atsuta, Shuichi Ota, Yukiyasu Ozawa, Yasuyuki Arai and Takashi Nagasawa and has published in prestigious journals such as Nature Communications, Blood and British Journal of Haematology.

In The Last Decade

Kazunari Aoki

24 papers receiving 298 citations

Peers

Kazunari Aoki
Silvia Trappolini Italy
Maria Dassi Italy
Anne‐Marie Manel France
Ruemu Birhiray United States
Bérengère Gruson France
A Molina United States
Zhihong Hu United States
Auayporn Nademanee United States
Cristina N. Alonso Argentina
Seren Durer United States
Silvia Trappolini Italy
Kazunari Aoki
Citations per year, relative to Kazunari Aoki Kazunari Aoki (= 1×) peers Silvia Trappolini

Countries citing papers authored by Kazunari Aoki

Since Specialization
Citations

This map shows the geographic impact of Kazunari Aoki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazunari Aoki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazunari Aoki more than expected).

Fields of papers citing papers by Kazunari Aoki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazunari Aoki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazunari Aoki. The network helps show where Kazunari Aoki may publish in the future.

Co-authorship network of co-authors of Kazunari Aoki

This figure shows the co-authorship network connecting the top 25 collaborators of Kazunari Aoki. A scholar is included among the top collaborators of Kazunari Aoki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazunari Aoki. Kazunari Aoki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Aoki, Kazunari, Yusuke Tarumoto, Gohei Nishibuchi, et al.. (2023). Canonical BAF complex regulates the oncogenic program in human T-cell acute lymphoblastic leukemia. Blood. 143(7). 604–618. 1 indexed citations
3.
Kondo, Tadakazu, Kazunari Aoki, Yasuyuki Arai, et al.. (2022). Significance of Omitting Day 11 Mini-Dose Methotrexate for GVHD Prophylaxis After Unrelated Bone Marrow Transplantation. Transplantation and Cellular Therapy. 29(2). 119.e1–119.e7. 5 indexed citations
4.
Omatsu, Yoshiki, Kazunari Aoki, Hitomi Watanabe, et al.. (2022). Runx1 and Runx2 inhibit fibrotic conversion of cellular niches for hematopoietic stem cells. Nature Communications. 13(1). 2654–2654. 26 indexed citations
5.
Aoki, Kazunari, Masako Kurashige, Michiko Ichii, et al.. (2021). Identification of CXCL12‐abundant reticular cells in human adult bone marrow. British Journal of Haematology. 193(3). 659–668. 34 indexed citations
6.
Itonaga, Hidehiro, Ken Ishiyama, Kazunari Aoki, et al.. (2019). Increased opportunity for prolonged survival after allogeneic hematopoietic stem cell transplantation in patients aged 60–69 years with myelodysplastic syndrome. Annals of Hematology. 98(6). 1367–1381. 14 indexed citations
7.
Itonaga, Hidehiro, Ken Ishiyama, Kazunari Aoki, et al.. (2019). Clinical impact of the loss of chromosome 7q on outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. 54(9). 1471–1481. 8 indexed citations
8.
Itonaga, Hidehiro, Kazunari Aoki, Jun Aoki, et al.. (2017). Prognostic Impact of Donor Source on Allogeneic Hematopoietic Stem Cell Transplantation Outcomes in Adults with Chronic Myelomonocytic Leukemia: A Nationwide Retrospective Analysis in Japan. Biology of Blood and Marrow Transplantation. 24(4). 840–848. 16 indexed citations
9.
Arai, Yasuyuki, Kazunari Aoki, June Takeda, et al.. (2015). Clinical significance of high-dose cytarabine added to cyclophosphamide/total-body irradiation in bone marrow or peripheral blood stem cell transplantation for myeloid malignancy. Journal of Hematology & Oncology. 8(1). 102–102. 26 indexed citations
10.
Yokohama‐Tamaki, Tamaki, Keishi Otsu, Hidemitsu Harada, et al.. (2015). CXCR4/CXCL12 signaling impacts enamel progenitor cell proliferation and motility in the dental stem cell niche. Cell and Tissue Research. 362(3). 633–642. 5 indexed citations
11.
12.
Aoki, Kazunari, Sumie Tabata, Noboru Yonetani, Akiko Matsushita, & Takayuki Ishikawa. (2013). The Prognostic Impact of Absolute Lymphocyte and Monocyte Counts at Diagnosis of Diffuse Large B-Cell Lymphoma in the Rituximab Era. Acta Haematologica. 130(4). 242–246. 25 indexed citations
13.
Aoki, Kazunari, Yuichiro Ono, Sumie Tabata, Akiko Matsushita, & Takayuki Ishikawa. (2013). Successful treatment of anti-erythropoietin antibody-mediated pure red cell aplasia with low-dose prednisolone. International Journal of Hematology. 97(2). 272–274. 3 indexed citations
14.
Nagano, Seiji, Minako Mori, Aiko Kato, et al.. (2013). Therapeutic Effects of Lenalidomide on Hemorrhagic Intestinal Myeloma-associated AL Amyloidosis. Internal Medicine. 52(10). 1101–1105. 3 indexed citations
15.
Takiuchi, Yoko, Hayato Maruoka, Kazunari Aoki, et al.. (2012). Leukemic Manifestation of Blastic Plasmacytoid Dendritic Cell Neoplasm Lacking Skin Lesion : A Borderline Case between Acute Monocytic Leukemia. Journal of Clinical and Experimental Hematopathology. 52(2). 107–111. 21 indexed citations
16.
Tabata, Sumie, Masayuki Kurata, June Takeda, et al.. (2012). [Fatal hepatic failure due to AL amyloidosis in a patient with multiple myeloma].. PubMed. 53(11). 1906–10. 3 indexed citations
17.
Ono, Yuichiro, Kazunari Aoki, Aiko Kato, et al.. (2011). Systemic Follicular Lymphoma with Massive Intestinal Involvement with Leukemic Manifestation. Journal of Clinical and Experimental Hematopathology. 51(2). 135–140. 3 indexed citations
18.
Inoue, Daichi, Kyoko Maruyama, Kazunari Aoki, et al.. (2011). Blastic Plasmacytoid Dendritic Cell Neoplasm Expressing the CD13 Myeloid Antigen. Acta Haematologica. 126(2). 122–128. 10 indexed citations
19.
Kato, Aiko, Yoko Takiuchi, Kazunari Aoki, et al.. (2011). Enteropathy-Associated T-Cell Lymphoma Type II Complicated by Autoimmune Hemolytic Anemia. Journal of Clinical and Experimental Hematopathology. 51(2). 119–123. 6 indexed citations
20.
Nagamura‐Inoue, Tokiko, Shunro Kai, Hiroshi Azuma, et al.. (2008). Unrelated cord blood transplantation in CML: Japan Cord Blood Bank Network analysis. Bone Marrow Transplantation. 42(4). 241–251. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silvia Trappolini Breakdown of academic impact, for papers by Maria Dassi Breakdown of academic impact, for papers by Anne‐Marie Manel Breakdown of academic impact, for papers by Ruemu Birhiray Breakdown of academic impact, for papers by Bérengère Gruson Breakdown of academic impact, for papers by A Molina Breakdown of academic impact, for papers by Zhihong Hu Breakdown of academic impact, for papers by Auayporn Nademanee Breakdown of academic impact, for papers by Cristina N. Alonso Breakdown of academic impact, for papers by Seren Durer
Rankless by CCL
2026